FLAMEL TECHNOLOGIES
Flamel Technologies SA is a specialty pharmaceutical company utilizing its core competencies in formulation development and drug delivery to develop safer and more efficacious pharmaceutical products, addressing unmet medical needs and/or reducing overall healthcare costs. Flamel currently markets three previously Unapproved Marketed Drugs ("UMDs") in the United States, Bloxiverz® (neostigmine methylsulfate injection), Vazculep® (phenylephrine hydrochloride injection), and Akovaz™ (ephedrine... sulfate injection). The Company also develops products utilizing its proprietary drug delivery platforms, Micropump® (oral sustained release microparticles platform), along with its tangent technologies, LiquiTime® (a Micropump-derivative platform for liquid oral products) and Trigger Lock™ (a Micropump-derivative platform for abuse-resistant opioids). Additionally, the Company has developed a long acting injectable platform, Medusa™, a hydrogel depot technology, particularly suited to the development of subcutaneously administered formulations. Current applications of Flamel's drug delivery products include sodium oxybate (Micropump®), extended-release of liquid medicines such as ibuprofen and guaifenesin (LiquiTime®, through a license arrangement with Elan Pharma International Limited for the U.S. Over-the-Counter market) and a current study of the delivery of exenatide utilizing the Medusa™ technology.
FLAMEL TECHNOLOGIES
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1990-01-01
Address:
Vénissieux, Rhone-Alpes, France
Country:
France
Website Url:
http://www.flamel.com
Total Employee:
251+
Status:
Active
Contact:
+33 4 72 78 34 34
Total Funding:
31 M USD
Technology used in webpage:
SPF Domain Not Resolving IPv6 Microsoft Azure DNS Apache 2.4 Microsoft Media Temple
Similar Organizations
Fagron SA
Fagron is a pharmaceutical company specializing in chemicals, equipment, and supplies solutions.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-01-03 | Avadel Pharmaceuticals | Avadel Pharmaceuticals acquired by Flamel Technologies | N/A |
| 2014-12-01 | Flamel Technologies SA | Flamel Technologies SA acquired by Flamel Technologies | N/A |
| 2012-03-13 | Éclat Pharmaceuticals | Éclat Pharmaceuticals acquired by Flamel Technologies | N/A |
Investors List
Official Site Inspections
http://www.flamel.com
- Host name: agaaacgege.gs11.gridserver.com
- IP address: 72.47.244.115
- Location: Culver City United States
- Latitude: 34.0141
- Longitude: -118.3983
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90232
